Papers
3
Total Citations
156
H-Index
3
About
Kawa Omar is a leading urological surgeon and researcher whose work centers on advancing surgical treatments for bladder cancer, with a particular focus on minimally invasive and robotic-assisted techniques. His most impactful contribution is the landmark CORAL trial, the first early-phase randomized controlled trial to directly compare open, robotic, and laparoscopic radical cystectomy. Published in 2019, this study has garnered 116 citations and provides critical long-term oncological outcomes that help guide surgical decision-making for patients with muscle-invasive bladder cancer. Omar has also made significant contributions to understanding the interplay between neoadjuvant chemotherapy and robotic cystectomy; his multinational study on suboptimal chemotherapy dosing (23 citations) revealed how treatment variations affect peri-operative outcomes and survival. Additionally, he developed a predictive model for operative times in robot-assisted radical cystectomy using data from the International Robotic Cystectomy Consortium (17 citations), a practical tool for improving operating room scheduling and quality control. Through these works, Omar has helped define best practices in robotic bladder cancer surgery, influencing both clinical protocols and future research directions in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3